MENINGIOMA team

SP1 – Molecular Drivers of Aggressive Meningiomas

  • Felix Sahm, PD Dr med, MBA — Uni­ver­si­ty Hos­pi­tal Hei­del­berg, Dept. of Neu­ropathol­o­gy, CCU Neu­ropathol­o­gy, Ger­man Can­cer Research Cen­ter (DKFZ)
  • Wolf­gand Wick, Prof Dr med – Uni­ver­si­ty Hos­pi­tal Hei­del­berg, Neu­rol­o­gy Clin­ic, CCU Neu­roon­col­o­gy, Ger­man Can­cer Research Cen­ter (DKFZ)

SP2 – Influence of Tumor-associated macrophages on infiltration and functional properties of T cells in aggressive meningiomas

  • Chris­tel Herold-Mende, Prof Dr rer nat – Uni­ver­si­ty Hos­pi­tal Hei­del­berg, Depart­ment of Neurosurgery 
  • Rolf Warta, Dr sc hum – Uni­ver­si­ty Hos­pi­tal Hei­del­berg, Depart­ment of Neurosurgery 

SP3 – Long non-coding RNAs (IncRNAs) as novel biomarkers and potential therapeutic targerts in atypical and anaplastic meningiomas

  • Gui­do Reifen­berg­er, Prof Dr med – Depart­ment of Neu­ropathol­o­gy, Hein­rich-Heine Uni­ver­si­ty Düsseldorf 
  • Marc Remke, Dr med – Depart­ment of Pedi­atric Oncol­o­gy, Hema­tol­ogy and Clin­i­cal Immunol­o­gy, Hein­rich-Heine Uni­ver­si­ty Düsseldorf
  • Bas­t­ian Malzko­rn, Dr med – Depart­ment of Neu­ropathol­o­gy, Hein­rich-Heine Uni­ver­si­ty Düsseldorf 

SP4 – Extracellular vesicles as biomarkers for meningioma subtypes and therapy response

  • Katrin Lam­szus, Prof Dr med – Depart­ment of Neu­ro­surgery, UKE Hamburg 
  • Franz Lennard Rick­lefs, Dr med – Depart­ment of Neu­ro­surgery, UKE Hamburg
  • Man­fred West­phal, Prof Dr med – Depart­ment of Neu­ro­surgery, UKE Hamburg 

SP5 – Spectromic characterization and classification of meningioma

  • Matthias Kirsch, Prof Dr med – Neu­ro­surgery, Uni­ver­si­ty Hos­pi­tal Carl Gus­tav Carus, TU Dresden 
  • Gabriele Schack­ert, Prof Dr med – Neu­ro­surgery, Uni­ver­si­ty Hos­pi­tal Carl Gus­tav Carus, TU Dresden

SP 6 – Deciphering the roles of SMO‑, KLF4- and TERT-mutations for meningioma aggressiveness

  • Chris­t­ian Mawrin, Prof Dr med – Depart­ment of Neu­ropathol­o­gy, Uni­ver­si­ty Hos­pi­tal Magdeburg 

SP 7 – Tumor metabolome reflects clinical aggressiveness of meningioma and impacts patient’s systematic metabolome

  • Chris­t­ian Schi­chor, PD Dr med – Neu­ro­sur­gi­cal Depart­ment Lud­wig-Max­i­m­il­ians Uni­ver­si­ty (LMU) Clin­ic Munich 
  • Jörg-Chris­t­ian Tonn, Prof Dr med – Neu­ro­sur­gi­cal Depart­ment Lud­wig-Max­i­m­il­ians Uni­ver­si­ty (LMU) Clin­ic Munich 

Z‑Project 1 – Identification of clinical prognostic and predictive factors, health-related quality of life and neurocognitive functioning in patients with aggressive meningiomas

  • Chris­tine Jungk Dr med – Uni­ver­si­ty Hos­pi­tal Hei­del­berg, Depart­ment of Neurosurgery

Z‑Project 2 – Molecular Profiling

  • Andreas von Deim­ling, Prof Dr med – Uni­ver­si­ty Hos­pi­tal Hei­del­berg, Depart­ment of Neu­ropathol­o­gy, CCU Neu­ropathol­o­gy, Ger­man Can­cer Research Cen­ter (DKFZ)